Milestone Pharmaceuticals
Price & Volume
Stats
See more52W Range | $1-$3.06 |
Market Cap | $158.1M |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $1.7M |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | $1.7M |
Diluted EPS | -$0.64 |
News
See moreYahoo Finance • last month
Paroxysmal Supraventricular Tachycardia Market Analysis Report 2026-2036, Profiles of Leading Players - Medtronic, Boston Scientific, Abbott Laboratories, Milestone Pharmaceuticals, Sanofi, Pfizer
Yahoo Finance • 2 months ago
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Yahoo Finance • 3 months ago
Milestone Pharmaceuticals Announces RESET-PSVT Registry to Generate Real-World Evidence on CARDAMYST™ (etripamil) Nasal Spray in Patients With PSVT
Yahoo Finance • 3 months ago
Etripamil Drives Milestone Pharma's Q4 Revenue; Eyes EMA Marketing Approval In H1,2027; Stock Up
About
CEO | Mr. Joseph G. Oliveto M.B.A. |
CFO | Mr. Amit Hasija |
Address | 1111 Dr. Frederik-Philips Boulevard, Montreal, QC, Canada, H4M 2X6 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 38 |